A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma.
Hiroyuki Takamatsu
No relevant relationships to disclose
Ryoichi Murata
No relevant relationships to disclose
Jianbiao Zheng
Employment or Leadership Position - Sequenta
Stock Ownership - Sequenta
Research Funding - Sequenta
Martin Moorhead
Employment or Leadership Position - Sequenta
Stock Ownership - Sequenta
Research Funding - Sequenta
Yasushi Terasaki
No relevant relationships to disclose
Takashi Yoshida
No relevant relationships to disclose
Malek Faham
Employment or Leadership Position - Sequenta
Stock Ownership - Sequenta
Research Funding - Sequenta
Shinji Nakao
No relevant relationships to disclose